We are live on
!
Find out more
BG
Bahl & Gaynor Portfolio holdings
AUM
$19.8B
1-Year Est. Return
19.53%
This Fund
S&P 500
This Quarter
Est. Return
+9.04%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$19.4B
AUM Growth
+$1.52B
(+8.5%)
Cap. Flow
+$55.8M
Cap. Flow
% of AUM
0.29%
Top 10 Holdings %
Top 10 Hldgs %
32.2%
Holding
350
New
17
Increased
136
Reduced
148
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$52.8M |
| 2 |
Oneok
OKE
|
+$39.9M |
| 3 |
Mondelez International
MDLZ
|
+$34.3M |
| 4 |
HP
HPQ
|
+$32.7M |
| 5 |
Travelers Companies
TRV
|
+$32.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$52.6M |
| 2 |
United Parcel Service
UPS
|
+$52.2M |
| 3 |
Chevron
CVX
|
+$43.4M |
| 4 |
Abbott
ABT
|
+$41.4M |
| 5 |
Eaton
ETN
|
+$36.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.95% |
| 2 | Financials | 14.09% |
| 3 | Healthcare | 13.94% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Staples | 10.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Adobe
ADBE
$105B
| $223K | ﹤0.01% |
430
| – | – |
|
327
Dow Inc
DOW
$21.2B
| $223K | ﹤0.01% |
4,073
-394
| -9% | -$20.8K |
|
328
Camden Property Trust
CPT
$11.3B
| $221K | ﹤0.01% |
+1,785
| New | +$211K |
|
329
Bank of Montreal
BMO
$127B
| $220K | ﹤0.01% |
2,436
| – | – |
|
330
Stanley Black & Decker
SWK
$15.7B
| $219K | ﹤0.01% |
+1,990
| New | +$191K |
|
331
TD Synnex
SNX
$20.2B
| $215K | ﹤0.01% |
1,793
| – | – |
|
332
Yum! Brands
YUM
$41.1B
| $210K | ﹤0.01% |
+1,500
| New | +$199K |
|
333
Boston Scientific
BSX
$71.5B
| $202K | ﹤0.01% |
+2,409
| New | +$190K |
|
334
Solventum
SOLV
$14.1B
| $200K | ﹤0.01% |
+2,871
| New | +$173K |
|
|
EFC
335
Ellington Financial
EFC
$1.71B
| $161K | ﹤0.01% |
12,500
| – | – |
|
336
Agilon Health
AGL
$1.6B
| $39.3K | ﹤0.01% |
400
| – | – |
|
337
Plug Power
PLUG
$3.04B
| $22.6K | ﹤0.01% |
10,000
| – | – |
|
|
LLAP
338
DELISTED
Terran Orbital Corporation
LLAP
| $16.3K | ﹤0.01% |
+65,000
| New | +$33K |
|
339
Cullen/Frost Bankers
CFR
$10.2B
| – | – |
-4,705
| Closed | -$478K |
|
340
Elevance Health
ELV
$85.5B
| – | – |
-373
| Closed | -$202K |
|
341
iShares MSCI Pacific ex Japan ETF
EPP
$2.28B
| – | – |
-9,330
| Closed | -$401K |
|
342
Hasbro
HAS
$13.2B
| – | – |
-3,826
| Closed | -$224K |
|
343
Lamb Weston
LW
$7.19B
| – | – |
-6,822
| Closed | -$574K |
|
344
Onconetix
ONCO
$3.29M
| – | – |
0
| – | -$5.8K |
|
345
Stepan Co
SCL
$1.48B
| – | – |
-19,467
| Closed | -$1.63M |
|
|
WBA
346
DELISTED
Walgreens Boots Alliance
WBA
| – | – |
-27,690
| Closed | -$335K |
|
Similar funds
NIM
HHII
SPIA
MIM
EIM
OSAM
P
Bahl & Gaynor's Q3 2024 Portfolio in Review
As of Q3 2024, Bahl & Gaynor held 350 positions worth $19.4B, up 8.5% from $17.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Bahl & Gaynor's Q3 2024 filing shows 17 new, 136 increased, 148 reduced and 7 closed positions. Its largest new stake was Gildan: 253,547 shares worth $11.9M. The largest sale was Amgen, an estimated $52.6M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Bahl & Gaynor's largest Q3 2024 buy was Gildan: 253,547 shares worth $11.9M.
- Bahl & Gaynor added most to PPL Corp in Q3 2024, an estimated $52.8M increase.
- Bahl & Gaynor's biggest Q3 2024 reduction was Amgen, cutting an estimated $52.6M.
- Bahl & Gaynor fully exited Stepan Co in Q3 2024, selling an estimated $1.63M.
- Bahl & Gaynor's ten largest holdings make up 32% of its $19.4B portfolio in Q3 2024.
- Bahl & Gaynor opened 17 new positions and closed 7 in Q3 2024.
- Bahl & Gaynor's portfolio value rose 8.5% quarter-over-quarter to $19.4B.
Based on Bahl & Gaynor's 13F filing for Q3 2024, filed 12 Nov 2024.